Browse studies

Find your next paid study

27,306 recruiting studies available now

Prospective, Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating a 4% Lidocaine Patch for Pain During Epidural Placement in Laboring Women

Needle phobia can negatively affect the patient experience and may contribute to anxiety during labor procedures. During epidural placement, a standard intrade…

Needle Phobia

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Ohio State UniversityNCT07700108

Phase 1

A Phase 1b Single Ascending Dose Study to Evaluate the Safety of VERVE-201 in Patients With Refractory Hyperlipidemia

VT-20101 is an Open-label, Phase 1b, Single-ascending dose study that will evaluate the safety of VERVE-201 administered to patients with Refractory Hyperlipid…

HypercholesterolemiaHypertriglyceridemiaRefractory Hyperlipidemia

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Verve Therapeutics, Inc.NCT06451770

Phase 1

Phase 1/1b First-in-human Study of Autologous Chimeric Engulfment Receptor T-Cell CER-1236 in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Myelofibrosis (CertainT-1)

This is a ﬁrst in human, multi center, open label, phase 1/1b study to evaluate the safety and preliminary efﬁcacy of CER-1236 in patients with relapsed/refrac…

AMLAcute Myeloid LeukemiaRefractory Acute Myeloid Leukemia

Estimated

~$150 – $4,200

Actual pay is set by the research site.

CERo Therapeutics Holdings, Inc.NCT06834282

Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support

This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane…

Drug Effect

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT03593408

Evaluation of Patients With Gastrointestinal Disease

Background: Ongoing and future research projects that study gastrointestinal diseases depend on access to biological samples and clinical data. Researchers wa…

Lower GI DiseaseGastrointestinal Diseases

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT05041374

Multi-scale Phenotyping of Heart Failure: From Precision Phenotyping to Population Inference (PHENO-HEART)

Background: More than 6.5 million people in the United States live with heart failure (HF), and more than a million new cases are diagnosed each year. Treatme…

Heart Failure

Estimated

~$10 – $675

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT06280820

The FLOW Registry: Functional and Longitudinal Outcomes With Waterjet Ablation

The purpose of this study is to create a database and prospective registry for data collection on patients with benign prostatic hyperplasia undergoing Aquabla…

Benign Prostatic Hyperplasia (BPH)

Estimated

~$10 – $750

Actual pay is set by the research site.

University of ChicagoNCT07430423

Observational

INSPIRED: Implementation of Novel Strategies to Promote Improvements in Referrals and Engagement for DSMES

A multicomponent implementation strategy bundle designed to improve Diabetes Self-Management Education and Support (DSMES) referral and utilization in rural pr…

Type Two Diabetes Mellitus

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Mary LacyNCT07888179

Phase 2

Phase II Trial of a Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

Background: Prostate cancer is the second most common cause of cancer-related death among men in the United States. Early-stage, low-grade prostate cancer is …

AdenocarcinomaProstate CancerNeoplasms+3 more

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07574541

Phase 1

A Randomized, Double-Masked, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ETHY-001

The primary objective of study is to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ETHY-001 in healthy volunteers and partici…

Thyroid Eye Disease (TED)Graves' DiseaseEye Diseases, Hereditary+11 more

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Ethyreal Bio, Inc.NCT07885605

Phase 2

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease

Background: Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect memory, attention, and thinking. Resear…

Alzheimer's Disease

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Institute on Aging (NIA)NCT07721467

Phase 1

A Multicenter, Sham-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Clinical Responses Following Stereotactic Intracranial Implantation of DSP-1083 Into Subjects With Parkinson's Disease

The Goal of this study is to evaluate the safety, tolerability, and clinical responses following implantation of DSP-1083. Study enrolls both male and female p…

Parkinson's Disease

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Sumitomo Pharma America, Inc.NCT06753331